Alterations of metagenomics and metaproteomics associate kidney disease in a combination of opisthorchiasis and nonalcoholic fatty liver disease
暂无分享,去创建一个
S. Roytrakul | S. Pinlaor | Chalongchai Chalermwat | P. Pinlaor | Sawanya Charoenlappanit | Chutima Sitthirach | S. Klungsaeng | Sirirat Anutrakulchai | Keerapach Tunbenjasiri | Thasanapong Pongking | Suppakrit Kongsintaweesuk
[1] H. Samadi kafil,et al. Chronic kidney disease and gut microbiota , 2023, Heliyon.
[2] N. Sanossian,et al. Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management , 2023, Food science & nutrition.
[3] V. Mordvinov,et al. Opisthorchis viverrini, Clonorchis sinensis and Opisthorchis felineus liver flukes affect mammalian host microbiome in a species-specific manner , 2023, PLoS neglected tropical diseases.
[4] Ampornpan Theeranut,et al. High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand , 2022, Scientific Reports.
[5] C. Pairojkul,et al. Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini , 2022, PloS one.
[6] Jia V. Li,et al. Opisthorchis viverrini infection induces metabolic disturbances in hamsters fed with high fat/high fructose diets: implications for liver and kidney pathologies. , 2022, The Journal of nutritional biochemistry.
[7] C. Kovesdy. Epidemiology of chronic kidney disease: an update 2022. , 2022, Kidney international supplements.
[8] P. Sithithaworn,et al. Association between Opisthorchis viverrini Infection and Glomerular Disease in Thailand , 2022, American Journal of Nephrology.
[9] Zhihong Liu,et al. Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis , 2021, Frontiers in Cellular and Infection Microbiology.
[10] Jia V. Li,et al. Opisthorchis viverrini Infection Induces Metabolic and Fecal Microbial Disturbances in Association with Liver and Kidney Pathologies in Hamsters. , 2021, Journal of proteome research.
[11] Minhu Chen,et al. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs , 2021, Frontiers in Microbiology.
[12] J. Duan,et al. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] G. Capasso,et al. Proteomics and metabolomics studies exploring the pathophysiology of renal dysfunction in autosomal dominant polycystic kidney disease and other ciliopathies. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] G. Chang-Chien,et al. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites , 2020, International journal of molecular sciences.
[15] S. Pinlaor,et al. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism , 2020, PloS one.
[16] Xiping Xu,et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents , 2020, Gut.
[17] J. Rajendhran,et al. Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease , 2020, Trends in Endocrinology & Metabolism.
[18] C. Pairojkul,et al. Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet-Fed Hamsters. , 2019, The American journal of tropical medicine and hygiene.
[19] E. Rhee,et al. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[20] Vinícius Andrade-Oliveira,et al. Inflammation in Renal Diseases: New and Old Players , 2019, Front. Pharmacol..
[21] G. Anton,et al. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome , 2018, Journal of immunology research.
[22] N. Vaziri,et al. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. , 2018, Clinical science.
[23] Zhibin Ning,et al. Proteomic and Metaproteomic Approaches to Understand Host-Microbe Interactions. , 2018, Analytical chemistry.
[24] Kianoush Kashani,et al. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. , 2016, Journal of thoracic disease.
[25] K. Kalantar-Zadeh,et al. The Gut as a Source of Inflammation in Chronic Kidney Disease , 2015, Nephron.
[26] D. Raj,et al. The gut microbiome, kidney disease, and targeted interventions. , 2014, Journal of the American Society of Nephrology : JASN.
[27] Robert C. Edgar,et al. UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.
[28] L. Krause,et al. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] B. Stecher,et al. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. , 2013, Kidney international.
[30] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[31] A. Sanyal,et al. Nonalcoholic fatty liver disease: Definitions, risk factors, and workup , 2012, Clinical liver disease.
[32] A. Loukas,et al. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. , 2012, Parasitology international.
[33] S. Liang,et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. , 2012, Parasitology international.
[34] Thomas J. Fuchs,et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. , 2010, Cancer cell.
[35] Mihai Pop,et al. Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..
[36] J. Tiedje,et al. Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.
[37] M. C. V. D. Heuvel,et al. Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.
[38] B. Sampaio-Maia,et al. The Role of the Gut Microbiome on Chronic Kidney Disease. , 2016, Advances in applied microbiology.
[39] S. Salzberg,et al. FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..
[40] G. Doungchawee,et al. Development of immune-complex glomerulonephritis and amyloidosis in Syrian golden hamsters infected with Opisthorchis viverrini. , 1992, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.